The DSCAM Knockout HAP1 Polyclonal Cells comprise a CRISPR/Cas9-edited, polyclonal knockout cell population carrying a targeted disruption of the human DSCAM (Down Syndrome Cell Adhesion Molecule) gene. This heterogeneous loss-of-function model is provided as a polyclonal pool, eliminating the need for single-cell cloning while retaining the biological complexity of a mixed population. The knockout is generated in the near-haploid HAP1 cell line, which facilitates direct genotype?Cphenotype correlations, making it a versatile tool for functional studies.
The HAP1 host cell line is a human near-haploid chronic myeloid leukemia derivative originally isolated from the KBM-7 line. With only one set of chromosomes, HAP1 cells are exceptionally suited for genetic perturbation studies, as a single targeting event is sufficient to generate a complete gene knockout. This cellular background retains essential components of adhesion, signaling, and cytoskeletal regulation, and is therefore widely employed in high-throughput genetic screens and mechanistic studies of cell-adhesion molecules.
DSCAM encodes a member of the immunoglobulin superfamily that functions as a netrin-1 receptor in axon guidance and neural self-avoidance. Upon netrin-1 binding, DSCAM cooperates with the DCC co-receptor and UNC5C to activate Rho GTPase signaling cascades. Key downstream effectors include the kinases PAK1 and RAC1, as well as the GTPase RHOA, leading to cytoskeletal reorganization. The transcription factor PAX6 has been identified as an upstream regulator of DSCAM expression. Consequently, DSCAM serves as a critical nexus that transduces extracellular guidance cues into intracellular remodeling, with dysfunction linked to neurodevelopmental disorders such as Down syndrome, congenital heart defects, and autism spectrum disorder.
Disruption of DSCAM in HAP1 cells eliminates netrin-1?Cdependent adhesive and signaling functions, creating a clean background to investigate the molecular consequences of its loss. The polyclonal composition of this knockout pool captures a spectrum of editing alleles, providing a population-level model that avoids clonal bias. This system is particularly valuable for dissecting how DSCAM influences netrin-1?Cinduced PAK1 phosphorylation, actin cytoskeletal dynamics, and cell adhesion properties. The haploid nature of HAP1 ensures that the knockout is functionally homozygous at the population level, yielding robust phenotypes for studying adhesion defects associated with Down syndrome and related conditions.
Key research applications include quantitative cell adhesion assays to measure substrate attachment in the absence of DSCAM. Netrin-1 stimulation experiments, followed by detection of phospho-PAK1 via Western blotting or ELISA, allow precise quantification of signaling output. Co-immunoprecipitation approaches with netrin-1, DCC, or PAK1 enable mapping of residual interactor binding. Immunofluorescence staining of F-actin reveals alterations in cytoskeletal architecture. Furthermore, the HAP1 background supports high-throughput chemical and genetic screens to identify factors that modulate DSCAM-related phenotypes. For additional information, please contact Ascent Research.
